Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Risk Stratification Model for Neurocognitive Outcome After Transplant and Feasibility of an Early Cognitive Intervention Program

NCT02300961 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02300961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02300961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Risk Stratification Model for Neurocognitive Outcome After Transplant and Feasibility of an Early Cognitive Intervention Program
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2014
Completion date
February 3, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, pediatric cancer, stem cell transplantation